Both TβRII and TβRII-B mRNA expression was detected in primary AML cells, normal bone marrow CD34+ cells, and four AML cell lines (U937, KG-1, NB4, and HEL). This evidence concerns the gene TGFBR2 and acute myeloid leukemia.